Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Agilent Technologies, Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
A · NYSE · Healthcare · Diagnostics and Research
$173.02-2.2%Nov 12 close
Next earnings: November 23, 2026 · after the close
Figures through July 31, 2026, from the 10-Q filed September 1, 2026
Agilent sells laboratory supplies and maintenance services, plus scientific instruments, to pharmaceutical companies, hospitals, research labs and testing laboratories.
Company outlook: revenue of $7.5B to $7.5B for Fiscal year 2026 — up 7.9% on a year earlier